2026-04-11T06:13:43Z https://pub.unibl.org/oai

oai:pub.unibl.org:40609 2026-01-06T04:43:32Z

Pharmacokinetics and Safety of Three Formulations of Rituximab (CT-P10, US-sourced Innovator Rituximab and EU-sourced Innovator Rituximab) in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks /unibl/author/Chang Hee Suh /unibl/author/Alfredo Berrocal Kasay /unibl/author/Elias Chalouhi El-Khouri /unibl/author/Pedro Miranda https://www.unibl.org/sr-lat/fis/zaposlen/3403-ljubinka-bozic /unibl/author/Slawomir Jeka /unibl/author/Pawel Hrycaj /unibl/author/Dmytro Rekalov /unibl/author/Piotr Wiland /unibl/author/Andreas Krause /unibl/author/Istvan Szombati /unibl/author/Anna Mihailova /unibl/author/Ihor Hospodarskyy /unibl/author/Mariusz Piotrowski /unibl/author/Seong Ryul Kwon /unibl/author/Eun Young Lee /unibl/author/Dae Hyun Yoo /unibl/author/Won Park /unibl/author/Seung Cheol Shim /unibl/author/Sang Joon Lee /unibl/author/Taek S. Kwon 2016-09 Academic Article text 101 100 /unibl/sci/idNaucniRad:24618 STED Journal 2637-2150 STED Journal 2637-2150 C. Hee Suh, A. Berrocal Kasay, E. Chalouhi El-Khouri, P. Miranda, LJ. Božić, S. Jeka, P. Hrycaj, D. Rekalov, P. Wiland, A. Krause, I. Szombati, A. Mihailova, I. Hospodarskyy, M. Piotrowski, S. Ryul Kwon, E. Young Lee, D. Hyun Yoo, W. Park, S. Cheol Shim, S. Joon Lee, T. S. Kwon, Pharmacokinetics and Safety of Three Formulations of Rituximab (CT-P10, US-sourced Innovator Rituximab and EU-sourced Innovator Rituximab) in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks, STED Journal, pp. 100 - 101, Sep, 2016 https://pub.unibl.org/s/cir/item/40609